Allied BioScience consults with some of the country’s leading scientific minds to deliver long-lasting solutions. Listed below are those distinguished scientists and academics currently serving on our scientific advisory board.
Alan Gao, Ph.D.
Dr. Gao is technical director and manager of the Genomics and Microarray Core Laboratory at the Cancer Center at the University of Colorado Denver. Dr. Gao’s research interests focus on understanding molecular mechanisms associated with progression of castration-resistant prostate cancer and metastasis to bone with the goal of identification of potential therapeutic targets for prostate cancer. Dr. Gao has served numerous NCI, DOD and VA merits, and ACS review panels including SPORE and PPG study sections.
Charles P. Gerba, Ph.D.
Dr. Gerba is a professor in the Department of Soil, Water and Environmental Science at the University of Arizona. He conducts research on the transmission of pathogens through the environment. His recent research encompasses the transmission of pathogens by water, food and fomites (surface contamination); fate of pathogens in land-applied wastes; development of new disinfectants; domestic microbiology; and microbial risk assessment. He is the author of more than 500 articles and several books on environmental microbiology, risk assessment and pollution science. Dr. Gerba is a fellow of the American Academy of Microbiology, American Association for the Advancement of Science, and the International Water Association. Read more of Dr. Gerba’s publications on the US National Library of Medicine on PubMed.gov
Brooks M. Hybertson, MBA, Ph.D.
Dr. Hybertson is a clinical associate professor at the University of Colorado School of Medicine. His work has included basic and applied studies of oxygen radical chemistry and biology. He is an author of more than 45 peer-reviewed journal articles and book chapters and is an inventor on seven issued patents. He also has been a principal investigator for research projects in materials science, clean technologies, supercritical fluids, oxidative stress, water treatment, disinfection, molecular biology, pulmonary science and biotechnology.
Daniel A. Moros, M.D.
Dr. Moros is associate clinical professor of neurology at Icahn School of Medicine at Mount Sinai in New York City. His specialization is in movement disorders and behavioral neurology. He has spent many years in the pharmaceutical industry as vice chairman and medical director of Taro Pharmaceutical Co. Ltd. with responsibilites for generic and new drug development and regulatory affairs. In addition to numerous publications in medical ethics and the philosophy of medicine, for the last two decades, Dr. Moros has co-taught a graduate course in medical ethics at the City University of New York and Icahn School of Medicine.
J. David Musgraves, Ph.D.
Dr. Musgraves teaches and conducts research in materials science at Clemson University. His area of research specialization involves photocatalytic properties of titanium-based materials. He served as a research assistant in the Materials Science & Engineering Department at the University of Arizona, where he developed techniques for a novel nanostructured thin-film deposition process. His research findings have been published in the Journal of Materials Research, the American Journal of Physics and in the proceedings of the Materials Research Society’s Symposium on Synthesis and Metrology of Nanoscale Oxides and Thin Films.
Elias A. Shaheen, Ph.D., MBA
Dr. Shaheen recently retired from The Clorox Company where he served as a Research Director, Healthcare Division. At Clorox, he played a key role in developing and executing the environmental disinfection platform. He developed and managed extensive external network with leading academic experts that resulted in mutually beneficial and productive collaborations. Dr. Shaheen has a broad range of expertise in public health and environmental microbiology with more than 30 years of extensive experience with antimicrobial agents and disinfectants, infection control and prevention, open innovation and strategic planning. He holds 12 US patents in the area of environmental hygiene and disinfection and has published numerous peer-reviewed papers, abstracts, book chapters and technical papers. Prior to joining Clorox, Dr. Shaheen held positions with Yamanouchi Pharmaceutical, Pillsbury, ARCO Chemical, and University of Florida.
Anthony F. Vuturo, M.D., M.P.H.
Dr. Vuturo is senior vice president for Canyon Ranch Health Resorts and was director of preventive medicine for the U.S. Civil Administration, a U.S. State Department program in Japan, and director of preventive medicine for Whitaker Corporation in Saudi Arabia. He is president of VSF International Ltd., a global health consulting firm. Dr. Vuturo is board certified in family practice, preventive medicine and medical management. He is a former professor and dean of health affairs for the College of Medicine at Arizona Health Science Center.
Ronald Wysocki Jr., Ph.D.
Dr. Wysocki serves as program director of chemistry and biochemistry at The Ohio State University and was the director of the Chemical Synthesis Facility in the Department of Chemistry at the University of Arizona. Formerly, he was chief scientist at Pharos Pharmaceuticals Inc. in Green Valley, Arizona; the senior chemist at Discovery Therapeutics Inc. in Richmond, Virginia; and the scientist and group leader for Whitby Research Inc. in Richmond, Virginia. Dr. Wysocki’s research areas include organic thin films, transmembrane proteins and various aspects of spectroscopy. He holds several U.S. patents in his area of research.